Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors
Clinical trial NCT03393962 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT03393962
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2028-01-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.